STUDY QUESTION: Is PGD associated with the risk of adverse perinatal outcomes such as pre-term birth (PTB) and low birth weight (LBW)?
Introduction
Pregnancies following ART are associated with a higher risk of adverse obstetric and perinatal outcomes compared with naturally conceived pregnancies (Schieve et al., 2007; Pinborg et al., 2013) . There is a higher incidence of pre-term birth (PTB) and low birth weight (LBW) following IVF treatment mainly due to the higher incidence of multiple pregnancies and multiple births (McDonald et al., 2009 (McDonald et al., , 2010 . However, studies have also reported an increased risk of PTB and LBW in singleton pregnancies following IVF compared with spontaneously conceived pregnancies . The cause for the risk of adverse obstetric and perinatal outcomes is attributed to the underlying infertility itself (Williams et al., 1991; Henriksen et al., 1997; Luke et al., 2016) . It is also suggested that the various processes and techniques during IVF are associated with and are contributory to the risk of the adverse outcomes (Olivennes et al., 1993; Sundström et al., 1997; Pinborg et al., 2013) .
Successful pregnancies following PGD were first described in 1990, performed to prevent transmission of X-linked diseases (Handyside et al., 1990) . PGD has since been implemented in couples with genetic conditions involving structural or numerical chromosomal imbalances and single gene disorders to avoid disease transmission to the offspring. PGD involves biopsy of the embryo, either removal of one or two blastomeres at the six to eight cell stage or more recently a trophectoderm biopsy involving the removal of few (50-100) cells at the blastocyst stage. The European Society of Human Reproduction and Embryology PGD consortium was established with an aim of collecting annual data from centres worldwide. The latest such report (13th) that was published on cycles performed in the year 2010 recorded 2753 oocyte retrievals and 795 clinical pregnancies following PGD from 62 participating centres (full PGD consortium members) (De Rycke et al., 2015) .
Long-term follow-up data of children born following PGD or PGS have shown similar post-natal growth up to the age of 2 years when compared with spontaneously conceived children (Desmyttere et al., 2009) . Early neonatal follow-up data showed no significant difference in birth measurements' between PGD and ICSI children and there was no significant difference in gestational age at birth (Desmyttere et al., 2009) . However, these immediate and longer term follow-up studies did not distinguish between fresh and frozen embryo transfer cycles in the ART groups, which would be important to differentiate in the light of data showing differing obstetric and perinatal outcomes for fresh and frozen transfers Evans et al., 2014) . The main aim of our study is to determine whether performing PGD has an influence on the perinatal outcomes of PTB and LBW following IVF treatment. We used a large national (UK) database involving 505 185 stimulated fresh IVF ± ICSI cycles and 2 122 fresh PGD cycles with 87 571 and 439 singleton live births, respectively, between the periods 1996-2011 to address this question.
Materials and Methods
Anonymous data were obtained from the Human Fertilization and Embryology Authority (HFEA), the statutory regulator of ART in the UK. Information was obtained on all ART cycles carried out at all centres in the UK between January 1996 and December 2011. Information on all variables and outcomes was submitted prospectively to the HFEA by all centres for all ART cycles. The information is validated by the HFEA. A total of 804 510 ART cycles were recorded prospectively during this period. For the purpose of this study, only stimulated fresh IVF ± ICSI and fresh PGD treatment cycles were analysed. Data were obtained for the age group of the women (≤34, 35-37, 38-39, 40-42, 43-44 and ≥45 years), treatment period (1996-2000, 2001-2005 and 2006-2011) , cause of infertility (male factor, tubal disease, ovulatory disorder, endometriosis, unexplained and cervical factors), infertility diagnosis (yes or no), previous IVF cycles, previous live birth (yes or no), number of oocytes retrieved, whether IVF or ICSI was used, number of embryos created, day of embryo transfer, live birth occurrence, singleton live births and gestational age at delivery and birth weight. Live birth was defined as delivery of a living baby at ≥24 weeks gestation and included both singleton and multiple births; however, only singleton live births were compared for perinatal outcomes of PTB, early PTB, LBW and very LBW. The occurrence of a live birth at <37 weeks gestation was defined as a PTB and <32 weeks as an early PTB. Birth weight <2500 g was defined as LBW and <1500 g as very LBW.
Statistical analysis
The characteristics of the cohorts (stimulated fresh IVF ± ICSI and fresh PGD cycles) are described using relative frequencies for categorical variables and means or medians with measures of spread for continuous variables. Crude live birth and singleton live birth rates were computed for the individual cohorts. Distributions of the cohorts are described stratified by female age categories, period of treatment, cause of infertility, infertility diagnosis (yes or no), previous treatment cycles, previous live birth occurrence, number of oocytes collected, whether IVF or ICSI was used, number of embryos created and day of embryo transfer (< day 5 versus ≥ day 5). Data on all stimulated fresh IVF ± ICSI and fresh PGD cycles were analysed to compare live birth rates, singleton live birth rates and perinatal outcomes (PTB, early PTB, LBW and very LBW). Multiple births were excluded from the analysis for perinatal outcomes of PTB, early PTB, LBW and very LBW. Adjusted logistic regression was performed for each perinatal outcome for confounding factors: female age category, period of treatment, infertility diagnosis (yes or no), number of previous IVF cycles, number of oocytes (≤20 versus >20), whether IVF or ICSI was used and day of embryo transfer (< day 5 versus ≥ day 5). Potential confounders were selected as any factor on which we had information and which were known or suspected to be related to clinical outcome. A P value <0.05 was considered statistically significant. Data were analysed using the statistical package Stata, version 13 (StataCorp, College Station, TX).
Results
From the initial cohort of 804 510 ART cycles, 297 203 cycles were excluded from the analysis for reasons as stated in Fig. 1 , following which 2 122 fresh PGD cycles and 505 185 stimulated fresh IVF ± ICSI cycles were eligible for analysis. There were 543 live births following PGD and 119 363 live births following stimulated autologous fresh IVF cycles. There were 91 multiple births with PGD cycles and 29 115 multiple births with stimulated IVF. There were 13 PGD live births and 2 677 live births following autologous IVF ± ICSI cycles with missing information on birth weights and gestational age at delivery which were excluded from the analysis. There were therefore 439 and 87 571 singleton live births, respectively, following PGD and stimulated fresh IVF ± ICSI cycles (totalling to 88 010 singleton live births) that were included in the analysis.
Baseline characteristics of the two cohorts are detailed in Table I . The age distribution was similar in both the groups. More cycles were in women aged ≤34 years compared with other age ranges, 46% in the PGD group and 46.3% in the autologous IVF group were in women aged ≤34 years. A majority of cycles in the PGD group had no infertility diagnosis implying that infertility was not the primary indication for performing PGD, whereas infertility (one or more causes) was the predominant indication for undergoing autologous IVF treatment. The numbers of both PGD and autologous IVF cycles increased over the time periods so that 68.5% PGD cycles and 46.8% autologous IVF cycles were in the time period 2006-2011. The median number of oocytes retrieved with PGD cycles was 11 [interquartile range (IQR) 8-16] and the median number of oocytes with autologous IVF cycles was 9 (IQR 5-13). In the PGD group, the majority (79.5%) of cycles had ICSI and 20.4% had conventional IVF without ICSI, whereas the majority (55.4%) of cycles had conventional IVF in the autologous IVF group with 44.8% having ICSI. The median number of embryos created with PGD cycles was 7 (IQR 4-10) and the median number of embryos created following autologous stimulated IVF cycles was 5 (IQR 2-8). The majority, 65.5% of PGD cycles, had fresh embryo transfer on or after day 5 following the oocyte retrieval compared with 10% in the autologous IVF group, 90% of cycles in the autologous IVF group and 34.5% of PGD cycles had fresh embryo transfer on before day 5.
Live birth outcomes following PGD and autologous IVF PGD did not have a higher risk of PTB or LBW. This is the first and largest study analysing perinatal outcomes following fresh PGD cycles excluding frozen embryo transfer cycles.
Previous literature has shown that underlying infertility alone is associated with adverse pregnancy outcomes (Williams et al., 1991; Henriksen et al., 1997; McElrath and Wise, 1997) . Infertility diagnosis was therefore considered as a confounding factor for the adjusted analysis. The number of oocytes retrieved was considered in the adjusted analysis consequent to the evidence from our previous study which demonstrated a significantly higher incidence of PTB and LBW following ovarian stimulation and IVF in women with >20 oocytes compared with women with 10-15 oocytes (Sunkara et al., 2015) . Studies have shown differences in perinatal and neonatal outcomes following blastocyst versus cleavage stage transfers with blastocyst transfers being associated with a higher risk of perinatal mortality and adverse perinatal outcomes (Källén et al., 2010; Maheshwari et al., 2013; Dar et al., 2014; Ginström Ernstad et al., 2016) . A recent study has shown lower birth weight following ICSI compared with spontaneously conceived pregnancies (Eldar-Geva et al., 2014) . In accordance with the evidence, number of oocytes, method of fertilization (IVF or ICSI) and day of embryo transfer were adjusted in the analysis for adverse perinatal outcomes. There were differences in other baseline characteristics between the two cohorts such as female age category, previous IVF attempts and year of treatment, which were also considered as confounders.
The main strengths of the study are the size of the data set and adjustment for important confounders. The limitations included the lack of information on variables such as maternal body mass index, smoking status and medical history during pregnancy. There was no information on the stage of embryo biopsy, whether blastomere or trophectoderm biopsy nor the indication for PGD and the anonymized nature of the data set did not allow analysis of one cycle per woman. The inability to account for correlated outcomes within centres is also likely to be a limitation. The findings of our study correlate with previous study findings, which demonstrated no increased adverse perinatal risks following PGD and PGS over IVF pregnancies (Desmyttere et al., 2012) implying safety of embryo biopsy. Whether the results of our study demonstrating a lower risk of the adverse perinatal outcomes following PGD could be due to residual confounding or some other factor remains open. Our study included only fresh transfer cycles whereas frozen-thawed cycles were included in the previous studies (Liebaers et al., 2010; Desmyttere et al., 2012; Eldar-Geva et al., 2014) . A recent study involving a Danish cohort found comparable neonatal outcomes of PTB and LBW between PGD versus IVF/ICSI pregnancies (Bay et al., 2016) . This study had a much higher incidence of PTB (20.6% following PGD versus 20.1% following IVF/ICSI) and LBW (18.4% following PGD versus 18.5% following IVF/ICSI) compared with our study and previous literature, which could perhaps be explained that both singleton and multiple births were included together in their analysis. Another recently published study on the outcomes of IVF and PGD involving the US Assisted Reproductive Technology Surveillance data from 2011-2012 reported outcomes of PTB and LBW but did not specify excluding multiple births in assessing these risks (Chang et al., 2016) . Although there was no information on the stage of the embryo at biopsy, it may be assumed that the earlier period within the data set would have more blastomere biopsy than the current due to the increasing trend towards trophectoderm biopsy. Initial safety data suggest that trophectoderm biopsy is safer than blastomere biopsy in terms of immediate damage to the embryo (Scott et al., 2013a) .
The emergence of 'new PGS' with trophectoderm biopsy and comprehensive chromosome screening of all 23 chromosomes has reinvigorated interest in aneuploidy screening to improve IVF success. Although evidence on the clinical efficacy of 'new PGS' is awaited from robust RCTs, initial smaller studies have shown benefit (Yang et al., 2012; Forman et al., 2013; Scott et al., 2013b) resulting in an increase in uptake of the new PGS. There has also been a trend to increasing PGD cycles according to registries (www.hfea.gov.uk/docs, 2014; De Rycke et al., 2015) . The results of this study are therefore of interest and of current relevance in providing reassurance that PGD is not associated with higher risk of adverse perinatal events and interventions such as embryo biopsy did not introduce the perinatal risks.
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